The Lancet Neurology
@thelancetneuro.bsky.social
The Lancet Neurology is the leading journal in clinical neurology. We publish articles and reviews that advocate change in, or illuminate, clinical practice.
🌐 https://www.thelancet.com/journals/laneur/home
🌐 https://www.thelancet.com/journals/laneur/home
LISTEN: In the latest podcast episode, host Antonia Eisenkoeck speaks with Ian McKeith. They delve into the history of dementia with Lewy bodies research, highlighting key milestones and breakthroughs: www.buzzsprout.com/1391383/epis...
Ian McKeith on dementia with dementia with Lewy bodies - The Lancet Neurology in conversation with
In this episode, host Antonia Eisenkoeck, speaks with Ian McKeith, Emeritus Professor of Old Age Psychiatry at Newcastle University, UK. They delve into the history of dementia with Lewy bodies resear...
www.buzzsprout.com
November 13, 2025 at 2:00 PM
LISTEN: In the latest podcast episode, host Antonia Eisenkoeck speaks with Ian McKeith. They delve into the history of dementia with Lewy bodies research, highlighting key milestones and breakthroughs: www.buzzsprout.com/1391383/epis...
SERIES: A collection of three papers highlight the latest advancements in basic and clinical research that are transforming the approach to disease management in Lewy body dementia: www.thelancet.com/series-do/de...
Advances in Dementia with Lewy Bodies
Lewy body dementia is a neurodegenerative disorder characterised by the accumulation of misfolded α-synuclein. The disease can disrupt cognitive function, motor function, autonomic regulation, and sle...
www.thelancet.com
November 13, 2025 at 2:00 PM
SERIES: A collection of three papers highlight the latest advancements in basic and clinical research that are transforming the approach to disease management in Lewy body dementia: www.thelancet.com/series-do/de...
In a Review, Tanuja Chitnis and colleagues provide an overview of the emerging evidence from studies that have assessed blood and CSF biomarkers and their clinical associations in patients with multiple sclerosis: thelancet.com/journals/lan...
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
Neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), chitinase-3-like
protein 1 (CHI3L1), and other protein assays are being developed as diagnostic or
prognostic biomarkers in mul...
thelancet.com
November 13, 2025 at 2:00 PM
In a Review, Tanuja Chitnis and colleagues provide an overview of the emerging evidence from studies that have assessed blood and CSF biomarkers and their clinical associations in patients with multiple sclerosis: thelancet.com/journals/lan...
In their Article, Clifford Jack and colleagues compute lifetime and 10-year absolute risk of cognitive impairment as a function of continuous amyloid PET: thelancet.com/journals/lan...
Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study
Lifetime and 10-year absolute risk for MCI and dementia among individuals who are
currently cognitively unimpaired increase with increasing biological severity of Alzheimer's
disease. This information...
thelancet.com
November 13, 2025 at 2:00 PM
In their Article, Clifford Jack and colleagues compute lifetime and 10-year absolute risk of cognitive impairment as a function of continuous amyloid PET: thelancet.com/journals/lan...
The latest analysis of data from the Global Burden of Disease Study 2023 presents updated results on headache-attributed burden from 1990 to 2023, along with clinical and public health implications: thelancet.com/journals/lan...
Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Headache disorders, in particular migraine, continue to be a major global health challenge,
emphasising the need for effective management and prevention strategies. Much headache-attributed
burden cou...
thelancet.com
November 13, 2025 at 2:00 PM
The latest analysis of data from the Global Burden of Disease Study 2023 presents updated results on headache-attributed burden from 1990 to 2023, along with clinical and public health implications: thelancet.com/journals/lan...